deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03170661

Effect of Deep Versus Moderate Neuromuscular Block During Sevoflurane Anesthesia on Intraoperative Surgical Conditions. (BLISS4)

Effect of Deep Versus Moderate Neuromuscular Block During Sevoflurane Anesthesia on Intraoperative Surgical Conditions in Patients Undergoing Laparoscopic Renal Surgery

Sponsor: Leiden University Medical Center

Conditions Surgical Conditions
Interventions Deep neuromuscular block
Updated 14 times since 2017 Last updated: Apr 21, 2021 Started: Jun 14, 2017 Primary completion: Apr 1, 2020 Completion: Jun 1, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Surgical Conditions and is currently completed. Leiden University Medical Center leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Oct 2019 · 15 months · monthly snapshot~Oct 2019 – ~Mar 2020 · 5 months · monthly snapshot~Mar 2020 – ~Aug 2020 · 5 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Jun 2021 · 3 months · monthly snapshot~Jun 2021 – ~Jun 2022 · 12 months · monthly snapshot~Jun 2022 – ~Dec 2022 · 6 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jun 2022 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 9 earlier versions

  1. Jun 2021 — Jun 2022 [monthly]

    Completed PHASE4

  2. Mar 2021 — Jun 2021 [monthly]

    Completed PHASE4

  3. Jan 2021 — Mar 2021 [monthly]

    Completed PHASE4

  4. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  5. Mar 2020 — Aug 2020 [monthly]

    Recruiting PHASE4

  6. Oct 2019 — Mar 2020 [monthly]

    Recruiting PHASE4

  7. Jul 2018 — Oct 2019 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  8. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE4

  9. Jul 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Leiden University Medical Center
  • Merck Sharp & Dohme LLC
Data source: Leiden University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations